Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approaching coronavirus disease 2019 (COVID-19) vaccine hesitancy among healthcare personnel: The importance of cultural competency.

Infection control and hospital epidemiology·2023
Same author

The role of environmental and healthcare-associated infections in Asia: Lessons learned from the coronavirus disease 2019 (COVID-19) pandemic.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2023
Same author

In-Person Instruction and Educational Outcomes of K-8 Students During the COVID-19 Pandemic.

Pediatrics·2023
Same author

Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model.

Bioorganic chemistry·2023
Same author

Transglutaminase 2 Binds to the CD44v6 Cytoplasmic Domain to Stimulate CD44v6/ERK1/2 Signaling and Maintain an Aggressive Cancer Phenotype.

Molecular cancer research : MCR·2023
Same author

Croquemort elicits activation of the immune deficiency pathway in ticks.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Dec 30, 2025

Murine Model of Epicutaneously-Induced Immunomodulation
09:06

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

382

Immunization of immunocompromised persons.

David J Weber1, William A Rutala

  • 1Adult Infectious Disease Division, University of North Carolina School of Medicine, CB #7030, Bioinformatics Building, 130 Mason Farm Road, Chapel Hill, NC 27599-7030, USA. dweber@unch.unc.edu

Immunology and Allergy Clinics of North America
|February 3, 2004
PubMed
Summary
This summary is machine-generated.

Vaccination is crucial for preventing infections in immunocompromised individuals, balancing benefits against risks. This review offers guidance on specific vaccines for those with altered host defenses.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Related Experiment Videos

Last Updated: Dec 30, 2025

Murine Model of Epicutaneously-Induced Immunomodulation
09:06

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

382
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Medical advances increase the population of individuals with compromised immune systems.
  • Immunocompromised hosts face heightened infection risks influenced by exposure and immunosuppression levels.

Purpose of the Study:

  • To review the benefits and risks of immunizations in immunocompromised populations.
  • To provide evidence-based recommendations for vaccine use in immunocompromised individuals.

Main Methods:

  • Literature review of existing studies on vaccination in immunocompromised patients.
  • Analysis of epidemiological data and clinical trial outcomes.
  • Synthesis of current guidelines and expert consensus.

Main Results:

  • Vaccination offers significant protection against various infections in immunocompromised hosts.
  • Potential risks associated with vaccines in this population are generally manageable.
  • Specific vaccine recommendations vary based on the degree of immunosuppression and individual risk factors.

Conclusions:

  • Immunization is a vital preventive strategy for immunocompromised individuals.
  • Careful consideration of vaccine benefits versus risks is essential.
  • Personalized vaccination schedules are recommended for optimal patient outcomes.